AG
XERS icon

Algert Global’s Xeris Biopharma Holdings XERS Stock Holding History

Algert Global’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.71M Buy
1,156,958
+438,114
+61% +$2.9M 0.1% 347
2025
Q4 		$5.64M Buy
718,844
+560,884
+355% +$4.41M 0.09% 388
2025
Q3 		$1.29M Buy
+157,960
New +$1.05M 0.02% 795
2021
Q3 		– Sell
-19,840
Closed -$81K – 1084
2021
Q2 		$81K Buy
+19,840
New +$75.7K 0.03% 399
2020
Q2 		– Sell
-12,020
Closed -$23K – 513
2020
Q1 		$23K Buy
+12,020
New +$51.7K 0.01% 398

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return